【结 构 式】 |
【分子编号】17840 【品名】8-chloro-11-(4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine 【CA登记号】 |
【 分 子 式 】C19H19ClN2 【 分 子 量 】310.82604 【元素组成】C 73.42% H 6.16% Cl 11.41% N 9.01% |
合成路线1
该中间体在本合成路线中的序号:(I)1) By carboxylation of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyctohepta[1,2-b]pyridine (I) with ethyl chloroformate (II) in refluxing benzene.
【1】 Magatti, C.V.; Villani, F.J.; Wong, J.; Poper, T.L.; Vashi, D.B.; N-substituted 11-(4-piperidylene)-5,6-dihydro-11H-. Arzneim-Forsch Drug Res 1986, 36, 9, 1311. |
【2】 Magatti, C.V.; Vashi, D.B.; Wong, J.; Poper, T.L.; Villani, F.J.; Derivatives of 10,11-dihydro-5H-dibenzola[a,d]cycl. J Med Chem 1972, 15, 7, 750. |
【3】 Villani, F.J. (Schering Corp.); Antihistaminic 11-(4-piperidylidene)-5H-benzo-[5,6. US 4282233 . |
【4】 Prous, J.; Castaner, J.; Loratadine. Drugs Fut 1987, 12, 6, 544. |
合成路线2
该中间体在本合成路线中的序号:(IX)N-tert-Butyl-3-methyl-2-pyridinecarboxamide (I) was treated with two equivalents of butyllithium at -40 C, and the resulting dianion was C-alkylated with 3-chlorobenzyl chloride (II) to provide the phenetylpyridine (III). Further refluxing with phosphoryl chloride afforded nitrile (IV), which was condensed with the piperidinyl Grignard reagent (V) to yield, after hydrolysis, ketone (VI). Acid-catalyzed cyclization of ketone (VI) produced the tricyclic compound (VII). Demethylation was then accomplished by conversion to the ethyl carbamate (VIII) by treatment with ethyl chloroformate, followed by hydrolysis to the N-unsubstituted piperidine (IX). Finally, acetylation of (IX) in the presence of pyridine provided the target amide.
【1】 Billah, M.M.; Green, M.J.; Wong, J.K.; Piwinski, J.J.; West, R.E. Jr.; Ganguly, A.K.; Kreutner, W.; Dual antagonists of platelet activating factor and histamine. Identification of structural requirements for dual activity of N-acyl-4-(5,6-dihydro-11H-benzo[5,6]cyclohepta-[1,2-b]pyridin-11-ylidene)piperidines. J Med Chem 1991, 34, 1, 457. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 16501 | N-(tert-butyl)-3-methyl-2-pyridinecarboxamide | C11H16N2O | 详情 | 详情 | |
(II) | 20642 | 1-chloro-3-(chloromethyl)benzene; 3-Chlorobenzyl chloride | 620-20-2 | C7H6Cl2 | 详情 | 详情 |
(III) | 20643 | N-(tert-butyl)-3-(3-chlorophenethyl)-2-pyridinecarboxamide | C18H21ClN2O | 详情 | 详情 | |
(IV) | 20644 | 3-(3-chlorophenethyl)-2-pyridinecarbonitrile | C14H11ClN2 | 详情 | 详情 | |
(V) | 20645 | chloro(1-methyl-4-piperidinyl)magnesium | C6H12ClMgN | 详情 | 详情 | |
(VI) | 20646 | [3-(3-chlorophenethyl)-2-pyridinyl](1-methyl-4-piperidinyl)methanone | C20H23ClN2O | 详情 | 详情 | |
(VII) | 20647 | 8-chloro-11-(1-methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine | 38092-89-6 | C20H21ClN2 | 详情 | 详情 |
(VIII) | 17877 | ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylate | 79794-75-5 | C22H23ClN2O2 | 详情 | 详情 |
(IX) | 17840 | 8-chloro-11-(4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine | C19H19ClN2 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(I)Isomerization of (I) in refluxing trifluoromethanesulfonic acid provided the endocyclic olefin (II). Further reaction with ethyl chloroformate and triethylamine in toluene gave carbamate (III), which was then nitrated with a cooled mixture tetra-n-butylammonium nitrate and trifluoroacetic anhydride in dicloromethane, to afford a mixture of nitrocompounds (IV) and (V). After separation by column chromatography on silica gel, nitrocompound (V )was reduced with iron powder and calcium chloride in refluxing aqueous ethanol to amine (VII). Diazotization of amine (VII) with NaNO2 in 48% HBr in the presence of bromine at -5 C gave a mixture of monobromide (VIII) and dibromide (IX), which were separated on column chromatography. The dibromocarbamate (IX) was hydrolyzed in refluxing HCl to amine (X), which was finally coupled with 4-pyridylacetic acid N-oxide (XI) by treatment with EDC and HOBT.
【1】 Njoroge, F.G.; et al.; Potent, selective, and orally bioavailable tricyclic pyridyl acetamide N-oxide inhibitors of farnesyl protein transferase with enhanced in vivo antitumor activity. J Med Chem 1998, 41, 10, 1561. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17840 | 8-chloro-11-(4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine | C19H19ClN2 | 详情 | 详情 | |
(II) | 17841 | 8-chloro-11-(4-piperidinyl)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine | C19H19ClN2 | 详情 | 详情 | |
(III) | 17842 | ethyl 4-(8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinecarboxylate | C22H23ClN2O2 | 详情 | 详情 | |
(IV) | 17843 | ethyl 4-(8-chloro-6-nitro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinecarboxylate | C22H22ClN3O4 | 详情 | 详情 | |
(V) | 17844 | ethyl 4-(8-chloro-3-nitro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinecarboxylate | C22H22ClN3O4 | 详情 | 详情 | |
(VII) | 17845 | ethyl 4-(3-amino-8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinecarboxylate | C22H24ClN3O2 | 详情 | 详情 | |
(VIII) | 17846 | ethyl 4-(3-bromo-8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinecarboxylate | C22H22BrClN2O2 | 详情 | 详情 | |
(IX) | 17847 | ethyl 4-(3,5-dibromo-8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinecarboxylate | C22H21Br2ClN2O2 | 详情 | 详情 | |
(X) | 17848 | 3,5-dibromo-8-chloro-11-(4-piperidinyl)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine | C19H17Br2ClN2 | 详情 | 详情 | |
(XI) | 17849 | 2-(1-hydroxy-1lambda(5)-pyridin-4-yl)acetic acid | C7H9NO3 | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(II)Carbamate (I) was hydrolyzed to amine (II) by treatment with an ethanolic solution of HCl, which was then isomerized to the endocyclic compound (III) on heating with trifluoromethanesulfonic acid. Compound III was protected as the carbamate (IV) by reaction with ethyl chloroformate, and further nitration was effected with tetra-n-butylammonium nitrate - trifluoroacetic anhydride (TFAA) reagent to afford nitro compound (V). Subsequent deprotection of carbamate was effected with ethanolic HCl, to give amine (VI), which was then condensed with 4-pyridylacetic acid (VII) to the amide (VIII). Reduction of the nitro group of (VIII) with tin (II) chloride yielded oxime (IX) (SCH 59948), and reaction of this compound with acetyl chloride gave the corresponding oxime acetate (SCH 60102).
【1】 del Rosario, J.D.; et al.; Benzocycloheptapyridine farnesyl protein transferase inhibitors: Effects of substitution at position 5 and 6 on enzyme inhibition. 213th ACS Natl Meet (April 13-17, San Francisco) 1997, Abst MEDI 198. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17877 | ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylate | 79794-75-5 | C22H23ClN2O2 | 详情 | 详情 |
(II) | 17840 | 8-chloro-11-(4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine | C19H19ClN2 | 详情 | 详情 | |
(III) | 17841 | 8-chloro-11-(4-piperidinyl)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine | C19H19ClN2 | 详情 | 详情 | |
(IV) | 17842 | ethyl 4-(8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinecarboxylate | C22H23ClN2O2 | 详情 | 详情 | |
(V) | 17843 | ethyl 4-(8-chloro-6-nitro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinecarboxylate | C22H22ClN3O4 | 详情 | 详情 | |
(VI) | 17882 | 8-chloro-6-nitro-11-(4-piperidinyl)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine | C19H18ClN3O2 | 详情 | 详情 | |
(VII) | 17883 | 2-(4-pyridinyl)acetic acid | 28356-58-3 | C7H7NO2 | 详情 | 详情 |
(VIII) | 17884 | 1-[4-(8-chloro-6-nitro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinyl]-2-(4-pyridinyl)-1-ethanone | C26H23ClN4O3 | 详情 | 详情 | |
(IX) | 17885 | 8-chloro-11-[1-[2-(4-pyridinyl)acetyl]-4-piperidinyl]-5,11-dihydro-6H-benzo[5,6]cyclohepta[1,2-b]pyridin-6-one oxime | C26H25ClN4O2 | 详情 | 详情 |